Form 483

MAZZONE PASTA, LLC Form 483, 2009-03-13

FDA issued a Form 483 to MAZZONE PASTA, LLC on 2009-03-13 with 8 public-safe observations.

483· Form 483 issued8 observations

MAZZONE PASTA, LLC · Bloomingdale, United States · Issued March 13, 2009

Overview

  • 8 public-safe observations are available for this inspection.
  • 8 structured CFR citations are represented.
  • 4 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

13 Mar 2009
21 CFR 110.35(b)(1)

Safe and adequate for use

Cited by Dariusz Galezowski, Brian P Emanuel, Bradley J Maunder, James E Roberts

13 Mar 2009
21 CFR 110.37(b)(3)

As source of contamination

Cited by Dariusz Galezowski, Brian P Emanuel, Bradley J Maunder, James E Roberts

13 Mar 2009
21 CFR 123.6(c)(2)

Critical control points

Cited by Dariusz Galezowski, Brian P Emanuel, Bradley J Maunder, James E Roberts

13 Mar 2009
21 CFR 123.6(c)(3)

Critical limits

Cited by Dariusz Galezowski, Brian P Emanuel, Bradley J Maunder, James E Roberts

13 Mar 2009
21 CFR 123.6(c)(5)

Corrective action plan

Cited by Dariusz Galezowski, Brian P Emanuel, Bradley J Maunder, James E Roberts

Inspected site

MPMAZZONE PASTA, LLCBloomingdale, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 110.35(b)(1)Cited across public-safe Form 483 observations1x
21 CFR 110.37(b)(3)Cited across public-safe Form 483 observations1x
21 CFR 123.11(b)Cited across public-safe Form 483 observations1x
21 CFR 123.6(c)(2)Cited across public-safe Form 483 observations1x
21 CFR 123.6(c)(3)Cited across public-safe Form 483 observations1x
21 CFR 123.6(c)(5)Cited across public-safe Form 483 observations1x
21 CFR 123.6(d)Cited across public-safe Form 483 observations1x
21 CFR 123.8(a)(2)(ii)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 8 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere